Safety and efficacy of apixaban versus other oral anticoagulants (dabigatran, rivaroxaban or warfarin) in elderly patients with non-valvular atrial fibrillation and concomitant coronary artery disease or peripheral arterial disease
Latest Information Update: 28 Nov 2017
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate; Rivaroxaban; Warfarin
- Indications Stroke; Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2017 New trial record
- 15 Nov 2017 Results presented at the 90th Annual Scientific Sessions of the American Heart Association